MedTrace Logo

PASS OCT® Post-market Clinical Follow-up

NCT02931279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-11-27

No results posted yet for this study

Summary

Prospective, multicenter non comparative and observational study (post-market clinical follow-up).

Patients operated with PASS OCT® manufactured by MEDICREA® INTERNATIONAL between July 2016 and July 2017.

The inclusion period will be 12 months and the follow-up 24 months

Conditions

  • Intervertebral Disc Disease
  • Spondylolisthesis
  • Spinal Stenosis
  • Spinal Neoplasms
  • Spinal Fractures

Interventions

DEVICE

PASS OCT® Spinal System

Posterior osteosynthesis of the cervical and upper thoracic spine

Sponsors & Collaborators

  • Medicrea International

    lead INDUSTRY

Principal Investigators

  • Stephane Fuentes, MD · Hopital la Timone, Marseille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02931279 on ClinicalTrials.gov